Results 171 to 180 of about 1,892,351 (211)

Therapeutic Phlebotomy in Patients With Grade 1 Hypertension: A Randomized-Controlled Trial

open access: yesJournal of Integrative and Complementary Medicine, 2022
Aim: Study aim was to investigate the effects of therapeutic phlebotomy on ambulatory blood pressure in patients with grade 1 hypertension. Methods: In this randomized-controlled intervention study, patients with unmedicated hypertension grade 1 were randomized into an intervention group (phlebotomy group; 500 mL bloodletting at baseline and after 6 ...
Benno Brinkhaus   +2 more
exaly   +4 more sources

Therapeutic Erythrocytapheresis Versus Phlebotomy in the Initial Treatment of Hereditary Hemochromatosis – A Pilot Study

open access: yesTransfusion and Apheresis Science, 2007
Hereditary Hemochromatosis (HH) is a genetic disorder of iron metabolism, resulting in excessive iron overload. Currently, phlebotomy is the standard effective treatment that prevents progression of tissue damage. Aim of the therapy is to reach ferritin levels between 20 and 50mugl(-1).
Eva Rombout-Sestrienkova, Ger H Koek
exaly   +4 more sources

Therapeutic Phlebotomy

2019
Yelena Z Ginzburg
exaly   +2 more sources

Iron Deficiency Due to Excessive Therapeutic Phlebotomy in Hemochromatosis [PDF]

open access: yesAmerican Journal of Hematology, 2000
Thirteen adults (eight men, five women) with hemochromatosis had undergone routine iron depletion therapy but while on maintenance phlebotomies developed iron deficiency which persisted for 25 +/- 13 (mean +/- 1 SD) months before diagnosis. All had symptoms and signs of iron deficiency. Levels of transferrin saturation were 10% +/- 5% (1 SD), and serum
James C. Barton   +2 more
exaly   +3 more sources

Diagnostic and Therapeutic Phlebotomy in Hemochromatosis With Anemia

New England Journal of Medicine, 1957
THIS report is concerned principally with the correction, by means of repeated phlebotomies, of moderate anemia and neutropenia, probably caused by hypersplenism, in a patient with idiopathic hemochromatosis. It also emphasizes that anemia per se is not a contraindication to embarking on a therapeutic phlebotomy program. Finally, it illustrates how the
Roy N Barnett, Stuart C Finch, S C Finch
exaly   +3 more sources

How do I…perform therapeutic phlebotomy?

Transfusion, 2021
AbstractBackgroundTherapeutic phlebotomy (TP) is a well‐established medical intervention that evolved from the historical practice of bloodletting.MethodsPatients who require TP are not infrequently told by their health‐care providers to “just go donate blood,” but TP should always be offered in the context of a prescribed course of therapy.
Alexis R. Peedin, Julie Katz Karp
openaire   +2 more sources

Self-Sustainability with Therapeutic Phlebotomy, a Solution to the National Blood Crisis?

Blood, 2023
CONCLUSION Hereditary hemochromatosis (HH) is a genetic condition associated with iron overload in the human body. The mainstay of treatment remains therapeutic phlebotomy. On August 1st, 2022, the American Red Cross approved using blood obtained from therapeutic phlebotomy for transfusion.
Madhan Srinivasan Kumar   +6 more
openaire   +1 more source

Therapeutic Phlebotomy

Journal of Infusion Nursing, 2010
In the United States, phlebotomies are most often performed for reinfusion of blood to a designated or nondesignated recipient at a later time. These are known, respectively, as autologous or allogenic donations. For a few rare blood disorders, however, phlebotomy is performed as a medical intervention for disease management.
openaire   +2 more sources

Home - About - Disclaimer - Privacy